drugset / Trial / NCT03546283

Neuroprotectant for Hypertensive Intracerebral Hemorrhage

NCT03546283 ↗

Phase 3 Unknown 422 enrolled Rong Hu, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Cattle encephalon glycoside and ignotin Cattle encephalon glycoside and ignotin (CEGI) injection (drug approval H22025046; Jilin Sihuan Pharmaceutical Co. LTD., Jilin, People's Republic of China) is a compound preparation of muscle extract from healthy rabbits and cattle brain gangliosides, which was approved by the Chinese Food and Drug Administration in 2011 and was commonly used as neuroprotectant in the treatment of central and peripheral nerve injuries in China. To evaluate the safety and efficacy of CEGI in treatment of Hypertensive intracerebral hemorrhage, we designed this study.

Timeline

Start
2018-06-15
Primary completion
2020-07-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cattle Encephalon Glycoside and Ignotin Other / unclassified — —